? To harness the therapeutic potential of stem cells for the treatment of diabetes novel technologies will need to be developed. First, stem cells will be have to be isolated and expanded. Second, the stem cells will have to undergo directed and controlled differentiation toward the beta-cell lineage. Finally, fully functional beta-cells must be isolated from the resulting complex mixes of cells. In this application, we propose to develop reagents that will assist in the further development of all three of these steps. We will generate a comprehensive panel of monoclonal antibodies directed against cell surface epitopes of murine, primate and human pancreatic cells. These antibodies will permit the fractionation of pancreatic cell suspensions using fluorescence activated cell sorting and/or magnetic bead panning. This approach can be used to isolate pancreatic stem cells (step 1) as well as for the purification of differentiated progeny before therapeutic transplantation (step 3). In addition, this proposal is designed to identify the network of genes controlled by the pancreatic transcription factor, PDX-1. Evidence suggests that the family of protein-coding genes under the control of PDX-1 defines many of the phenotypic characteristics of differentiated beta cells. Although a few of these genes have been identified, the full constellation of PDX-1 responsive targets is unknown. We propose that PDX-1 also drives the expression of non-coding genes that are equally important for regulating beta cell function (steps 2&3). Definition of both families of targets is required for a complete understanding of beta cell biology and pathophysiology ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project--Cooperative Agreements (U01)
Project #
3U01DK072477-01S1
Application #
7125278
Study Section
Special Emphasis Panel (ZDK1)
Program Officer
Sato, Sheryl M
Project Start
2005-08-01
Project End
2009-07-31
Budget Start
2005-08-01
Budget End
2006-07-31
Support Year
1
Fiscal Year
2005
Total Cost
$92,000
Indirect Cost
Name
Oregon Health and Science University
Department
Genetics
Type
Schools of Medicine
DUNS #
096997515
City
Portland
State
OR
Country
United States
Zip Code
97239
Wang, Yuhan; Dorrell, Craig; Naugler, Willscott E et al. (2018) Long-Term Correction of Diabetes in Mice by In Vivo Reprogramming of Pancreatic Ducts. Mol Ther 26:1327-1342
Hickey, Raymond D; Galivo, Feorillo; Schug, Jonathan et al. (2013) Generation of islet-like cells from mouse gall bladder by direct ex vivo reprogramming. Stem Cell Res 11:503-15
Keller, David M; Clark, Elizabeth A; Goodman, Richard H (2012) Regulation of microRNA-375 by cAMP in pancreatic ýý-cells. Mol Endocrinol 26:989-99
Dorrell, Craig; Grompe, Maria T; Pan, Fong Cheng et al. (2011) Isolation of mouse pancreatic alpha, beta, duct and acinar populations with cell surface markers. Mol Cell Endocrinol 339:144-50
Gadue, Paul; Gouon-Evans, Valerie; Cheng, Xin et al. (2009) Generation of monoclonal antibodies specific for cell surface molecules expressed on early mouse endoderm. Stem Cells 27:2103-13
Dorrell, Craig; Abraham, Stephanie L; Lanxon-Cookson, Kelsea M et al. (2008) Isolation of major pancreatic cell types and long-term culture-initiating cells using novel human surface markers. Stem Cell Res 1:183-94
Zaret, Kenneth S; Grompe, Markus (2008) Generation and regeneration of cells of the liver and pancreas. Science 322:1490-4
Keller, David M; McWeeney, Shannon; Arsenlis, Athanasios et al. (2007) Characterization of pancreatic transcription factor Pdx-1 binding sites using promoter microarray and serial analysis of chromatin occupancy. J Biol Chem 282:32084-92